ClinicalTrials.Veeva

Menu
T

The University of Adelaide | PARC Clinical Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PTC923
REN001
LAT8881
Mavodelpar
MIS416
Tamoxifen
XG004
BGE-117
Diclofenac Gel

Parent organization

This site is a part of The University of Adelaide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from b...

Enrolling
Phenylketonuria
Drug: PTC923

The goal of this clinical trial is to compare 1% and 3% diclofenac gel (DARE-PDM1) to placebo in women with symptomatic primary dysmenorrhea. The mai...

Active, not recruiting
Dysmenorrhea Primary
Drug: Placebo
Drug: Diclofenac 3%

Trial sponsors

Daré Bioscience logo
PTC Therapeutics logo
R
B
CSL Behring logo
I
L
Moderna logo
X
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems